228 related articles for article (PubMed ID: 31704171)
1. Charting a TRP to Novel Therapeutic Destinations for Kidney Diseases.
Pablo JL; Greka A
Trends Pharmacol Sci; 2019 Dec; 40(12):911-918. PubMed ID: 31704171
[TBL] [Abstract][Full Text] [Related]
2. TRPC Channels in Proteinuric Kidney Diseases.
Hall G; Wang L; Spurney RF
Cells; 2019 Dec; 9(1):. PubMed ID: 31877991
[TBL] [Abstract][Full Text] [Related]
3. Renal TRPathies.
Dietrich A; Chubanov V; Gudermann T
J Am Soc Nephrol; 2010 May; 21(5):736-44. PubMed ID: 20395377
[TBL] [Abstract][Full Text] [Related]
4. TRP channels in kidney disease.
Hsu YJ; Hoenderop JG; Bindels RJ
Biochim Biophys Acta; 2007 Aug; 1772(8):928-36. PubMed ID: 17346947
[TBL] [Abstract][Full Text] [Related]
5. TRP channels as therapeutic targets in kidney disease and hypertension.
Menè P; Punzo G; Pirozzi N
Curr Top Med Chem; 2013; 13(3):386-97. PubMed ID: 23432067
[TBL] [Abstract][Full Text] [Related]
6. TRPC6 and FSGS: the latest TRP channelopathy.
Mukerji N; Damodaran TV; Winn MP
Biochim Biophys Acta; 2007 Aug; 1772(8):859-68. PubMed ID: 17459670
[TBL] [Abstract][Full Text] [Related]
7. A small-molecule inhibitor of TRPC5 ion channels suppresses progressive kidney disease in animal models.
Zhou Y; Castonguay P; Sidhom EH; Clark AR; Dvela-Levitt M; Kim S; Sieber J; Wieder N; Jung JY; Andreeva S; Reichardt J; Dubois F; Hoffmann SC; Basgen JM; Montesinos MS; Weins A; Johnson AC; Lander ES; Garrett MR; Hopkins CR; Greka A
Science; 2017 Dec; 358(6368):1332-1336. PubMed ID: 29217578
[TBL] [Abstract][Full Text] [Related]
8. The small GTPase regulatory protein Rac1 drives podocyte injury independent of cationic channel protein TRPC5.
Polat OK; Isaeva E; Sudhini YR; Knott B; Zhu K; Noben M; Suresh Kumar V; Endlich N; Mangos S; Reddy TV; Samelko B; Wei C; Altintas MM; Dryer SE; Sever S; Staruschenko A; Reiser J
Kidney Int; 2023 Jun; 103(6):1056-1062. PubMed ID: 36750145
[TBL] [Abstract][Full Text] [Related]
9. Cryo-EM structure of the cytoplasmic domain of murine transient receptor potential cation channel subfamily C member 6 (TRPC6).
Azumaya CM; Sierra-Valdez F; Cordero-Morales JF; Nakagawa T
J Biol Chem; 2018 Jun; 293(26):10381-10391. PubMed ID: 29752403
[TBL] [Abstract][Full Text] [Related]
10. Regulation of TRPC6 ion channels in podocytes - Implications for focal segmental glomerulosclerosis and acquired forms of proteinuric diseases.
Szabó T; Ambrus L; Zákány N; Balla G; Bíró T
Acta Physiol Hung; 2015 Sep; 102(3):241-51. PubMed ID: 26551740
[TBL] [Abstract][Full Text] [Related]
11. The role of transient receptor potential channels in kidney disease.
Woudenberg-Vrenken TE; Bindels RJ; Hoenderop JG
Nat Rev Nephrol; 2009 Aug; 5(8):441-9. PubMed ID: 19546862
[TBL] [Abstract][Full Text] [Related]
12. TRPC channels: Regulation, dysregulation and contributions to chronic kidney disease.
Dryer SE; Roshanravan H; Kim EY
Biochim Biophys Acta Mol Basis Dis; 2019 Jun; 1865(6):1041-1066. PubMed ID: 30953689
[TBL] [Abstract][Full Text] [Related]
13. TRPC6 channel as an emerging determinant of the podocyte injury susceptibility in kidney diseases.
Ilatovskaya DV; Staruschenko A
Am J Physiol Renal Physiol; 2015 Sep; 309(5):F393-7. PubMed ID: 26084930
[TBL] [Abstract][Full Text] [Related]
14. Balancing calcium signals through TRPC5 and TRPC6 in podocytes.
Greka A; Mundel P
J Am Soc Nephrol; 2011 Nov; 22(11):1969-80. PubMed ID: 21980113
[TBL] [Abstract][Full Text] [Related]
15. TRPC6 in glomerular health and disease: what we know and what we believe.
Schlöndorff JS; Pollak MR
Semin Cell Dev Biol; 2006 Dec; 17(6):667-74. PubMed ID: 17116414
[TBL] [Abstract][Full Text] [Related]
16. Ion channels and channelopathies in glomeruli.
Staruschenko A; Ma R; Palygin O; Dryer SE
Physiol Rev; 2023 Jan; 103(1):787-854. PubMed ID: 36007181
[TBL] [Abstract][Full Text] [Related]
17. Pharmacological inhibition of focal segmental glomerulosclerosis-related, gain of function mutants of TRPC6 channels by semi-synthetic derivatives of larixol.
Urban N; Neuser S; Hentschel A; Köhling S; Rademann J; Schaefer M
Br J Pharmacol; 2017 Nov; 174(22):4099-4122. PubMed ID: 28800680
[TBL] [Abstract][Full Text] [Related]
18. The Calcium-Dependent Protease Calpain-1 Links TRPC6 Activity to Podocyte Injury.
Verheijden KAT; Sonneveld R; Bakker-van Bebber M; Wetzels JFM; van der Vlag J; Nijenhuis T
J Am Soc Nephrol; 2018 Aug; 29(8):2099-2109. PubMed ID: 29954830
[TBL] [Abstract][Full Text] [Related]
19. Synthesis of AC1903 analogs as potent transient receptor potential canonical channel 4/5 inhibitors and biological evaluation.
Chen L; Zhang Z; Tian H; Jiang S; Ji Y; Liu M; Shen J; Cao Z; Wang K
Bioorg Med Chem; 2022 Aug; 68():116853. PubMed ID: 35653869
[TBL] [Abstract][Full Text] [Related]
20. Structural mechanism of human TRPC3 and TRPC6 channel regulation by their intracellular calcium-binding sites.
Guo W; Tang Q; Wei M; Kang Y; Wu JX; Chen L
Neuron; 2022 Mar; 110(6):1023-1035.e5. PubMed ID: 35051376
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
